Aurinia Announces Participation at the 20th Annual Global Investment Conference in New York City September 4-6, 2018 Aug 28, 2018
Aurinia Pharmaceuticals to Release Second Quarter 2018 Financial Results on August 9, 2018 Jul 30, 2018
Aurinia Initiates Phase 2 Clinical Trial for Voclosporin Ophthalmic Solution for the Treatment of Dry Eye Syndrome Jul 11, 2018
Aurinia Pharmaceuticals Recognizes World Lupus DayTM with Activities Focused on Raising Awareness of Lupus Nephritis May 10, 2018
Aurinia to Present at the Bloom Burton & Co. Healthcare Investor Conference on May 3, 2018 Apr 25, 2018
